AbbVie Earnings Beat Estimates as Botox Shows Signs of Revival

AbbVie Inc. reported second quarter profit and sales that topped Wall Street’s expectations, driven by strong demand across its immunology and neuroscience franchises and further signs of a recovery in Botox.